Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $3.60 billion. The enterprise value is $11.02 billion.
| Market Cap | 3.60B |
| Enterprise Value | 11.02B |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | Aug 14, 2026 |
Share Statistics
Organon & Co. has 262.61 million shares outstanding. The number of shares has increased by 1.39% in one year.
| Current Share Class | 262.61M |
| Shares Outstanding | 262.61M |
| Shares Change (YoY) | +1.39% |
| Shares Change (QoQ) | +2.87% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 77.28% |
| Float | 242.99M |
Valuation Ratios
The trailing PE ratio is 17.29 and the forward PE ratio is 3.92. Organon & Co.'s PEG ratio is 1.17.
| PE Ratio | 17.29 |
| Forward PE | 3.92 |
| PS Ratio | 0.59 |
| Forward PS | 0.57 |
| PB Ratio | 3.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.35 |
| P/OCF Ratio | 4.88 |
| PEG Ratio | 1.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.05, with an EV/FCF ratio of 19.43.
| EV / Earnings | 52.72 |
| EV / Sales | 1.80 |
| EV / EBITDA | 7.05 |
| EV / EBIT | 9.11 |
| EV / FCF | 19.43 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 8.50.
| Current Ratio | 1.95 |
| Quick Ratio | 1.00 |
| Debt / Equity | 8.50 |
| Debt / EBITDA | 5.23 |
| Debt / FCF | 15.08 |
| Interest Coverage | 2.59 |
Financial Efficiency
Return on equity (ROE) is 24.04% and return on invested capital (ROIC) is 6.14%.
| Return on Equity (ROE) | 24.04% |
| Return on Assets (ROA) | 5.67% |
| Return on Invested Capital (ROIC) | 6.14% |
| Return on Capital Employed (ROCE) | 11.46% |
| Weighted Average Cost of Capital (WACC) | 5.37% |
| Revenue Per Employee | $612,700 |
| Profits Per Employee | $20,900 |
| Employee Count | 10,000 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.04 |
Taxes
In the past 12 months, Organon & Co. has paid $282.00 million in taxes.
| Income Tax | 282.00M |
| Effective Tax Rate | 57.43% |
Stock Price Statistics
The stock price has increased by +29.66% in the last 52 weeks. The beta is 1.52, so Organon & Co.'s price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +29.66% |
| 50-Day Moving Average | 13.65 |
| 200-Day Moving Average | 10.66 |
| Relative Strength Index (RSI) | 55.28 |
| Average Volume (20 Days) | 2,841,666 |
Short Selling Information
The latest short interest is 16.70 million, so 6.36% of the outstanding shares have been sold short.
| Short Interest | 16.70M |
| Short Previous Month | 16.81M |
| Short % of Shares Out | 6.36% |
| Short % of Float | 6.87% |
| Short Ratio (days to cover) | 5.80 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.13 billion and earned $209.00 million in profits. Earnings per share was $0.79.
| Revenue | 6.13B |
| Gross Profit | 3.27B |
| Operating Income | 1.21B |
| Pretax Income | 491.00M |
| Net Income | 209.00M |
| EBITDA | 1.56B |
| EBIT | 1.21B |
| Earnings Per Share (EPS) | $0.79 |
Balance Sheet
The company has $1.13 billion in cash and $8.55 billion in debt, with a net cash position of -$7.42 billion or -$28.26 per share.
| Cash & Cash Equivalents | 1.13B |
| Total Debt | 8.55B |
| Net Cash | -7.42B |
| Net Cash Per Share | -$28.26 |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 3.83 |
| Working Capital | 2.50B |
Cash Flow
In the last 12 months, operating cash flow was $737.00 million and capital expenditures -$170.00 million, giving a free cash flow of $567.00 million.
| Operating Cash Flow | 737.00M |
| Capital Expenditures | -170.00M |
| Depreciation & Amortization | 354.00M |
| Net Borrowing | -286.00M |
| Free Cash Flow | 567.00M |
| FCF Per Share | $2.16 |
Margins
Gross margin is 53.40%, with operating and profit margins of 19.75% and 3.41%.
| Gross Margin | 53.40% |
| Operating Margin | 19.75% |
| Pretax Margin | 8.01% |
| Profit Margin | 3.41% |
| EBITDA Margin | 25.53% |
| EBIT Margin | 19.75% |
| FCF Margin | 9.25% |
Dividends & Yields
This stock pays an annual dividend of $0.08, which amounts to a dividend yield of 0.58%.
| Dividend Per Share | $0.08 |
| Dividend Yield | 0.58% |
| Dividend Growth (YoY) | -86.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 10.09% |
| FCF Payout Ratio | 3.71% |
| Buyback Yield | -1.39% |
| Shareholder Yield | -0.80% |
| Earnings Yield | 5.81% |
| FCF Yield | 15.76% |
Analyst Forecast
The average price target for Organon & Co. is $11.25, which is -17.94% lower than the current price. The consensus rating is "Hold".
| Price Target | $11.25 |
| Price Target Difference | -17.94% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 1.16% |
| EPS Growth Forecast (3Y) | 0.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.26 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.26 |
| Piotroski F-Score | 6 |